El valor de la selección de pacientes en NSCLC: tratamiento de segunda línea en pacientes PD-L1 positivo - page 40

Slide 17

Presented By Roy Herbst at 2015 ASCO Annual Meeting

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,30,31,32,33,34,35,36,37,38,39 41,42,43